Fialip J, Marty H, Makambila M C, Civiale M A, Eschalier A
Laboratoire de Pharmacologie et de Pharmacie Clinique, Faculté de Pharmacie, Clermont-Ferrand, France.
J Pharmacol Exp Ther. 1989 Feb;248(2):747-51.
Many studies have shown tricyclic antidepressants (TCAs) to potentiate morphine analgesia, but more recent work, using different modes of administration, has revealed inhibition of morphine analgesia by TCAs. The influence of different modes of administration of clomipramine (CMI) on morphine analgesia assessed by the hot-plate test was studied in mice. The administration procedure was based on the pharmacokinetic parameters of CMI determined in the strain used. Acute and chronic (i.e., every half-life of 130 min for five half-lives) administration of CMI (10 or 20 mg/kg i.p.) had opposite effects; the former potentiated morphine analgesia and the latter inhibited it. Five closely repeated administrations (i.e., every 40 min) suppressed the potentiation without producing inhibition. The time course of the influence of CMI showed that the inhibition of morphine analgesia observed after repeated administration of a given dose of CMI occurred if the latter was present for sufficient time; this time decreased when the dose of CMI was increased. Moreover, comparison with literature data shows the importance of standardized patterns of repeated administration: the variability in the frequency of repeated administration and in the time-lag between the last injection of TCA and the test may account for the varying results observed. The discrepancies in the literature regarding TCA/morphine interaction are thus only apparent, and arise merely from varying conditions. Possible mechanisms for the CMI-morphine interaction are discussed: involvement of opiate receptors and/or the serotonergic system.
许多研究表明,三环类抗抑郁药(TCA)可增强吗啡的镇痛作用,但最近采用不同给药方式的研究显示,TCA会抑制吗啡的镇痛作用。本研究在小鼠中,通过热板试验评估了氯米帕明(CMI)不同给药方式对吗啡镇痛作用的影响。给药程序基于所用品系中CMI的药代动力学参数。急性和慢性(即每130分钟给药一次,共给药五个半衰期)给予CMI(10或20mg/kg,腹腔注射)具有相反的作用;前者增强吗啡镇痛作用,后者则抑制其镇痛作用。五次紧密重复给药(即每40分钟给药一次)可抑制这种增强作用,但不会产生抑制作用。CMI影响的时间进程表明,如果给予一定剂量的CMI后其在体内存在足够长的时间,就会观察到对吗啡镇痛作用的抑制;当CMI剂量增加时,所需时间会缩短。此外,与文献数据的比较表明了重复给药标准化模式的重要性:重复给药频率以及最后一次注射TCA与测试之间的时间间隔的变化,可能是观察到不同结果的原因。因此,文献中关于TCA/吗啡相互作用的差异只是表面现象,仅仅是由不同条件引起的。本文还讨论了CMI-吗啡相互作用的可能机制:阿片受体和/或5-羟色胺能系统的参与。